patent/FR-2772270-A1

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29d9e0d38217fd5cef1b25e772a8c87a
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
filingDate	1997-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb6039e621dea98dde6574e57f459539 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab657f26e3d37d7a58b7f1d4ba614b98
publicationDate	1999-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	FR-2772270-A1
titleOfInvention	USE OF AN ESTROGEN FOR THE TREATMENT OF POSTNATAL DEPRESSION
abstract	The subject of the invention is the use of an estrogen for the manufacture of a gel intended for the treatment of postnatal depression.
priorityDate	1997-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0409383-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0573133-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2518879-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554556 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757

Total number of triples: 17.